Erste Asset Management Gmb H Pfizer Inc Transaction History

Erste Asset Management Gmb H

$11.9 Trillion
Q2 2025

A detailed history of Erste Asset Management Gmb H transactions in Pfizer Inc stock. As of the latest transaction made, Erste Asset Management Gmb H holds 267,134 shares of PFE stock, worth $6.86 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

267,134

Previous 246,714 8.28%

Holding current value

$6.86 Million

Previous $6.22 Billion 3.92%

% of portfolio

0.05%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$21.59 - $24.84 $440,867 - $507,232	20,420 Added 8.28%	267,134 $6.46 Billion
Q1 2025 May 14, 2025	SELL	$25.01 - $27.13 $4.64 Million - $5.03 Million	-185,585 Reduced 42.93%	246,714 $6.22 Billion
Q4 2024 Feb 10, 2025	SELL	$24.8 - $30.19 $3.58 Million - $4.36 Million	-144,444 Reduced 25.04%	432,299 $11.5 Billion
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $16 Million - $18.1 Million	576,743 New	576,743 $16.8 Billion
Q2 2024 Nov 26, 2024	BUY	$25.26 - $29.6 $384,053 - $450,038	15,204 Added 3.22%	487,411 $13.6 Billion
Q1 2024 Nov 26, 2024	SELL	$25.89 - $29.73 $958,758 - $1.1 Million	-37,032 Reduced 7.27%	472,207 $13.1 Billion
Q4 2023 Nov 26, 2024	BUY	$26.13 - $33.94 $2.79 Million - $3.63 Million	106,929 Added 26.58%	509,239 $14.7 Billion
Q3 2023 Nov 26, 2024	SELL	$32.09 - $37.51 $27.8 Million - $32.5 Million	-865,614 Reduced 68.27%	402,310 $13 Billion
Q2 2023 Nov 26, 2024	BUY	$36.12 - $41.79 $2.63 Million - $3.04 Million	72,850 Added 6.25%	1,239,346 $45.1 Billion
Q1 2023 Nov 26, 2024	SELL	$39.39 - $51.28 $2.33 Million - $3.03 Million	-59,086 Reduced 4.82%	1,166,496 $47.3 Billion
Q4 2022 Nov 26, 2024	BUY	$41.75 - $54.5 $3.67 Million - $4.79 Million	87,843 Added 7.44%	1,267,924 $65 Billion
Q3 2022 Nov 26, 2024	BUY	$43.76 - $53.42 $28.4 Million - $34.7 Million	648,839 Added 112.5%	1,225,582 $54 Billion
Q2 2022 Nov 26, 2024	BUY	$46.53 - $55.17 $49.8 Million - $59 Million	1,069,661 Added 968.72%	1,180,081 $60.6 Billion
Q1 2022 Nov 22, 2024	BUY	$45.75 - $56.69 $32.4 Million - $40.1 Million	707,305 Added 377.42%	894,712 $46.8 Billion
Q4 2021 Nov 22, 2024	SELL	$41.32 - $61.25 $7.98 Million - $11.8 Million	-193,150 Reduced 33.49%	383,593 $22.1 Billion
Q3 2021 Nov 22, 2024	BUY	$39.25 - $50.42 $36,070 - $46,335	919 Added 0.49%	187,407 $8.15 Billion
Q2 2021 Nov 22, 2024	BUY	$35.91 - $40.68 $6.33 Million - $7.18 Million	176,405 Added 1749.53%	186,488 $7.29 Billion
Q1 2021 Nov 22, 2024	SELL	$33.49 - $37.77 $33,490 - $37,770	-1,000 Reduced 9.02%	10,083 $364 Million
Q4 2020 Nov 22, 2024	SELL	$33.47 - $42.56 $3.2 Million - $4.07 Million	-95,676 Reduced 89.62%	11,083 $409 Million
Q3 2020 Nov 22, 2024	SELL	$31.75 - $37.25 $14.9 Million - $17.5 Million	-469,984 Reduced 81.49%	106,759 $3.86 Billion
Q2 2020 Nov 22, 2024	BUY	$30.12 - $36.54 $1.14 Million - $1.38 Million	37,860 Added 49.78%	113,920 $3.72 Billion
Q1 2020 Nov 22, 2024	SELL	$27.03 - $38.62 $1.13 Million - $1.61 Million	-41,660 Reduced 35.39%	76,060 $2.48 Billion
Q4 2019 Nov 22, 2024	SELL	$32.92 - $37.36 $15.1 Million - $17.1 Million	-459,023 Reduced 79.59%	117,720 $4.63 Billion
Q3 2019 Nov 22, 2024	SELL	$32.49 - $42.13 $64,980 - $84,260	-2,000 Reduced 1.8%	109,220 $3.95 Billion
Q2 2019 Nov 22, 2024	SELL	$36.98 - $41.52 $1.13 Million - $1.26 Million	-30,430 Reduced 21.48%	111,220 $4.83 Billion
Q1 2019 Nov 22, 2024	SELL	$37.5 - $41.2 $16.3 Million - $17.9 Million	-435,093 Reduced 75.44%	141,650 $5.99 Billion
Q4 2018 Nov 26, 2024	SELL	$38.47 - $43.86 $17.9 Million - $20.5 Million	-466,323 Reduced 80.85%	110,420 $4.73 Billion

Others Institutions Holding PFE

# of Institutions

3,292

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Pfizer Inc Transaction History